A Montana legislative committee has shelved a bill that would have imposed new restrictions on kratom sales across the state, as reported by ksenam.com. The panel voted 8-1 to table the measure, leaving kratom’s legal status in Montana unchanged for now and setting up a likely return of the debate when the Legislature convenes in regular session in 2027.
What the Bill Would Have Done
The proposed legislation would have established a regulatory framework around kratom, a botanical substance derived from the leaves of a Southeast Asian tree. Kratom produces both stimulant-like and opioid-like effects depending on the dose, and it is currently sold legally in some Montana retail stores and gas stations.
Under the bill, synthetic kratom would have been banned outright. Products containing the substance would have been required to carry labels and pass testing standards. Sales would have been restricted to buyers 18 and older.
The Age Question and Competing Concerns
The 18-year age threshold drew scrutiny from at least one committee member. Sen. Vince Ricci raised the point that Montana already restricts alcohol, marijuana, and tobacco sales to those 21 and older, questioning why kratom would receive a lower threshold if regulators were treating it as a substance with potential for harm.
Medical professionals also weighed in with concerns. Doctors testified about kratom’s addiction potential and the difficulties users face when trying to stop. A pediatrician described treating a newborn going through withdrawal after the infant’s mother used kratom during pregnancy — testimony that illustrated the substance’s reach beyond adult consumers.
On the other side, some Montana residents defended their access to kratom. A segment of users describe it as a more affordable substitute for prescription opioids or illicit drugs like heroin, framing access to it as a harm-reduction option rather than a public health risk.
Where Things Stand
The 8-1 vote to table the bill means the proposal will not advance further during the current interim period. Montana’s Legislature does not hold a regular session in even-numbered years — the 69th session adjourned in 2025, and the next regular session is not scheduled until January 2027. Any substantive legislative action on kratom regulation would need to wait until that session unless the Governor were to call a special session, which has not been indicated.
Interim committee work like this shapes what proposals eventually reach the floor, meaning the debate over how — or whether — to regulate kratom will likely resume as the 2027 session draws closer. The lopsided vote suggests the current regulatory framework proposed did not find broad support among committee members, though the underlying concerns raised by medical witnesses and the age-restriction question remain unresolved.
Broader Context
Kratom regulation has become a flashpoint in several states as the substance grows more widely available and more visibly tied to both addiction treatment and dependency. Montana has not previously enacted kratom-specific restrictions, and the substance occupies a legal gray zone nationally — it is not scheduled under federal law, though the FDA has repeatedly flagged safety concerns.
The tabling vote reflects the difficulty of crafting policy around substances that draw support from both harm-reduction advocates and recreational users, while also generating genuine alarm from clinicians who see negative health outcomes firsthand. Whether Montana lawmakers return to the issue with a revised approach in 2027 will depend in part on whether public pressure or new medical evidence sharpens the case for action.
